May 10, 2019
1:140
For every 140 shares held, investors received 1.
The split itself did not change the total investment value.
Armata Pharmaceuticals, Inc. (GETTEX:TG1N) operates in the Biotechnology industry.
Armata Pharmaceuticals, Inc. company overviewArmata Pharmaceuticals, Inc.'s most recent stock split was on May 10, 2019. It was a 1-for-140 reverse split, so shareholders received 1 share for every 140 they held.
Armata Pharmaceuticals, Inc. (GETTEX:TG1N) has split its stock 4 times: a 1-for-10 reverse split on May 11, 2006, a 1-for-50 reverse split on August 7, 2015, a 1-for-10 reverse split on April 25, 2017, and a 1-for-140 reverse split on May 10, 2019.
Armata Pharmaceuticals, Inc. has split its stock 4 times. This history records 4 reverse splits between May 11, 2006 and May 10, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Armata Pharmaceuticals, Inc.'s 1-for-140 reverse split on May 10, 2019, every 140 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Armata Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on May 10, 2019, 7 years ago. Companies announce splits in advance, and any new GETTEX:TG1N split will appear on this page.